← LOYTI Newsletter

July 2022 · RETROSPECTIVE EDITION

July 2022: Creative tools, wider language access and useful open research

New access to images, translation research and protein predictions offers distinct lessons for business leaders.

July's developments showed that AI could create value in very different ways: helping people explore visual ideas, extending language research and making scientific predictions available at extraordinary scale. For business leaders, the common thread was access. More people could work with capabilities that previously required scarce resources. Access alone, however, did not establish product quality, suitability for commercial use or a return on investment. Those questions still needed separate answers.

1. DALL·E moves into a broader beta

OpenAI announced DALL·E's beta on July 20 and began inviting more people from its waitlist. The announcement allowed commercial use of generated images under the applicable terms. This was a staged expansion of access, not immediate access for everyone or a guarantee that every generated asset was suitable for every commercial purpose.

For a small business, the practical opportunity was concept development: exploring a visual direction before paying for final production. A team could compare different approaches to an illustration or campaign idea and use the result to improve its creative brief.

Business takeaway: choose a low-risk visual task and measure the entire process, including selection and editing. Review assets for misleading representations, brand consistency and rights considerations. Keep accurate product imagery and factual claims under deliberate control. The business benefit should be a clearer message or a more efficient creative process, not simply a larger volume of images.

Source: https://openai.com/index/dall-e-now-available-in-beta/

2. NLLB-200 broadens translation research

Meta announced NLLB-200 on July 6, a model covering 200 languages, alongside research resources and evaluation data. The release represented a substantial research step toward wider language coverage. Opening research assets did not automatically make them a turnkey, commercially licensed translation service for every business use case.

The business issue is familiar: a customer who cannot understand a form or service explanation may abandon the process. Broader language technology could help, but terminology, cultural context and the consequences of mistranslation vary significantly across tasks.

Business takeaway: prioritize languages based on real customer needs. Test a specific journey, such as understanding service options or completing an inquiry, with competent human reviewers. Check the license and deployment terms of any model before use. Maintain an escalation route for important or ambiguous communication. Count successful customer outcomes rather than assuming broader language coverage means every translation is dependable.

Source: https://about.fb.com/news/2022/07/new-meta-ai-model-translates-200-languages-making-technology-more-accessible/

3. AlphaFold expands the shared scientific starting point

On July 28, EMBL-EBI and DeepMind announced an expansion of the AlphaFold database to more than 200 million predicted protein structures. The predictions were made openly accessible. These were computational predictions that could support research, not proof of new drugs, completed experiments or immediate commercial products.

For leaders outside life sciences, the broader lesson is that a shared information resource can change where effort is spent. When a useful starting point becomes available, specialists can focus more attention on evaluating, applying and validating it. The value still depends on the expertise surrounding the data.

Business takeaway: examine whether your team repeatedly recreates information already available from a credible source. Before building or buying, check existing datasets, standards and reference material. Assess quality, licensing and maintenance. Reusing a trustworthy starting point can free resources for the part of the problem that is specific to your customers.

Source: https://www.ebi.ac.uk/about/news/technology-and-innovation/alphafold-200-million/

Choose access that leads to an outcome

These three developments call for different decisions. A creative tool may justify a small workflow test. A research translation model may justify investigation and careful license review. A scientific database may change a research team's information strategy. Grouping them together under a single AI budget would hide the differences that matter.

For your next project, identify what has become easier to access and what difficult work remains. Is the remaining challenge expert review, integration, customer understanding or reliable operation? That is where the implementation plan should concentrate. The most visible technology is not always the largest cost or the most important dependency.

Set a small experiment with a concrete deliverable and an honest comparison. For creative work, compare approved assets and total staff time. For language support, compare task completion and corrections. For information reuse, compare research effort and confidence in the source. These measures connect new capabilities to business decisions without assuming that every development belongs in production immediately.

Present-day invitation: Book a consultation with Brice Prather at https://loyti.com/book to discuss how AI, custom software or automation could improve a specific part of your business. Bring the task, the current friction and the result you want to make possible.

Original sources

  1. DALL·E now available in beta · 2022-07-20
  2. New AI Model Translates 200 Languages, Making Technology Accessible to More People · 2022-07-06
  3. AlphaFold predicts structure of almost every catalogued protein known to science · 2022-07-28